Sandoz GmbH is a CDMO of peptides based in Switzerland. Direct manufacturer. Founded 1886. Key products include biosimilars, generic pharmaceuticals.
Swiss CDMO and biosimilar specialist. Provides recombinant peptide and protein manufacturing via microbial fermentation. Serves global pharmaceutical market.
Sandoz GmbH is listed as a CDMO in the peptide supply chain, serving Europe markets from Switzerland. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.